3M Zukünftiges Wachstum

Future Kriterienprüfungen 2/6

3M wird ein jährliches Gewinn- und Umsatzwachstum von 12.1% bzw. 2.8% prognostiziert. Der Gewinn pro Aktie wird voraussichtlich wachsen um 13% pro Jahr. Die Eigenkapitalrendite wird in 3 Jahren voraussichtlich 69.9% betragen.

Wichtige Informationen

12.1%

Wachstumsrate der Gewinne

12.98%

EPS-Wachstumsrate

Industrials Gewinnwachstum	15.1%
Wachstumsrate der Einnahmen	2.8%
Zukünftige Eigenkapitalrendite	69.90%
Analystenabdeckung	Good
Zuletzt aktualisiert	15 May 2026

Jüngste Aktualisierungen zum künftigen Wachstum

Recent updates

Seeking Alpha • 14h

MMM: Operational Progress And Legal Overhang Resolution Will Support Future Re Rating

The analyst price target for 3M has been adjusted by a few dollars, reflecting mixed but generally constructive updates from recent research. Some firms raised their targets by $2 to $5, while others trimmed theirs by $6 to $8, based on refreshed views of growth, profitability, and valuation assumptions.

Narrativ-Update • Mar 06

MMM: Digital And Legal Progress Will Support Future Re Rating

The analyst price target for 3M has edged higher by about $1.50, as analysts weighed mixed target moves from major firms alongside slightly updated assumptions for fair value, discount rate, revenue growth, profit margin and future P/E. Analyst Commentary Recent Street research on 3M has been mixed, with some firms trimming their price targets while others raised theirs.

Narrativ-Update • Feb 20

MMM: Digital Execution And Slightly Higher Fair Value Will Support Re Rating

The analyst price target for 3M has shifted slightly higher, with our fair value estimate moving from $223.00 to about $225.67 as analysts factor in updated growth and margin assumptions, along with mixed target revisions across major firms. Analyst Commentary Recent Street research on 3M shows a split view, with several bullish analysts lifting price targets and others trimming expectations or downgrading the stock.

Narrativ-Update • Feb 05

MMM: Turnaround Prospects Will Be Tested By PFAS Litigation And Mixed Street Expectations

The analyst price target on 3M has been revised slightly higher to about $177 from $174, as analysts adjust their models for small changes in fair value, discount rate, revenue growth, profit margin, and future P/E assumptions following a mix of recent target increases and cuts across major firms. Analyst Commentary Recent Street research on 3M has been mixed, with several firms adjusting their price targets in both directions and one major downgrade.

Narrativ-Update • Jan 22

MMM: New Digital Tools And Higher P E Multiple Will Support Re Rating

Analysts have nudged their valuation view on 3M higher, with the updated fair value estimate moving from $212 to $223 as they reassess the stock's longer term earnings power and apply a slightly richer future P/E multiple, despite mixed recent price target changes across the Street. Analyst Commentary Recent Street research on 3M has been mixed, with some firms trimming targets or ratings and others lifting their valuation marks.

Narrativ-Update • Jan 07

MMM: Reset Expectations And New Products Will Support Higher Margins

Analysts have raised their fair value estimate for 3M to $212 from $187, citing expectations for higher profit margins, a slightly lower discount rate, and supportive Street research that highlights Q3 execution, new product traction, and reset expectations across multiple firms. Analyst Commentary Recent Street research around 3M clusters around a more constructive setup following Q3, with several bullish analysts revisiting their models on the back of reset expectations, new product traction, and updated legal and macro assumptions.

Narrativ-Update • Dec 24

MMM: PFAS Litigation Will Ultimately Cap Upside Despite Turnaround Progress

Analysts have raised their price target on 3M, lifting fair value by about $12 per share to roughly $126 as they grow more confident in the company’s improving organic growth, margin expansion, and turnaround initiatives, despite ongoing PFAS litigation risks. Analyst Commentary Recent Street research reflects a more balanced, but still risk aware, view on 3M as estimates reset and execution on the turnaround improves.

Narrativ-Update • Dec 10

MMM: Turnaround Progress Will Face Ongoing PFAS Litigation And Portfolio Reshaping Risks

Our fair value estimate for 3M has been trimmed slightly to $174.25 from $174.94 as analysts balance higher price targets and improving expectations for new product driven growth and management's turnaround progress against persistent PFAS litigation risk. Analyst Commentary Street research remains divided on 3M, with recent notes highlighting improving execution and product driven growth, offset by continued concern around PFAS liabilities and mixed end market demand.

Narrativ-Update • Nov 26

MMM: Shares Will Balance Turnaround Progress With Litigation and Asset Sale Uncertainty

Analysts have marginally raised their fair value estimate for 3M to $174.94, citing improved organic growth, ongoing new product introductions, and increased profit margin expectations following recent quarterly results. Analyst Commentary Recent analyst research has revealed a shifting perspective on 3M, as several experts adjust their outlooks based on the company’s latest earnings performance and ongoing strategic initiatives.

Narrativ-Update • Nov 06

MMM: Shares Will Balance Turnaround Progress With Ongoing Litigation and Portfolio Changes

Analysts have raised their fair value estimate for 3M to $174.31 from $167.81. This change reflects improved organic growth prospects and progress on turnaround initiatives highlighted in recent research updates.

Narrativ-Update • Oct 22

Analysts Divided on 3M as Fair Value Rises Amid New Initiatives and Persistent Risks

3M's fair value estimate has increased by $5.00 to $167.81 as analysts cite modest operating outperformance and positive momentum from new product initiatives, despite some lingering concerns. Analyst Commentary Recent updates from Street research highlight diverging analyst sentiment regarding 3M's valuation trajectory and execution on strategic initiatives.

Narrativ-Update • Oct 08

New Product Launches And Efficiency Gains Will Boost Future Value

Narrative Update: 3M Analyst Price Target Revision Analysts have increased their price target for 3M to $162.81 from $161.63, citing improved full-year guidance prospects and renewed interest as a short-term buy idea. Analyst Commentary Recent commentary from Street research highlights both optimistic and cautious stances regarding 3M’s near-term prospects.

Seeking Alpha • Mar 11

3M: Multiple Expansion Amidst Turnaround Success

Summary 3M has shown signs of a turnaround with a doubling stock price since October 2023, but operational top line growth remains modest, justifying a "hold" rating. The company expects modest organic revenue growth of 2-3% in 2025, driven by innovations and new product launches, but analysts are less optimistic. Current valuation is high with a forward P/E ratio above the five-year median, limiting upside potential amid risks like trade disputes and economic slowdowns. Read the full article on Seeking Alpha

Seeking Alpha • Feb 07

3M: More Upside Ahead - But Wait For A Moderate Retracement

Summary MMM's reversal is already here, thanks to the SOLV divestiture bringing forth a more focused portfolio and healthier balance sheet. This is on top of the resolution of its legal headwinds, as management also pursues insurance recovery and $340M already completed. The management has driven new growth opportunities through its legacy businesses and new product launches as well, despite certain market softness. These reasons are likely why the market has upgraded MMM's valuations and the investors have defended the stock's uptrend support line thus far. With double digit capital appreciation prospects, we are reiterating our Buy rating here with one caveat. We shall further discuss. Read the full article on Seeking Alpha

Seeking Alpha • Jan 23

3M Is Structurally Shifting For Durable Growth

Summary 3M's focus on innovation and operational improvements under CEO Bill Brown may lead to significant top-line growth and margin expansion. Management is aiming to enhance supply chain efficiencies and increasing production launches while improving the firm's on-time, in-full deliveries. 3M has a substantial amount of inventory that may be worked down in the coming quarters, potentially acting as a tailwind for free cash flow generation in the coming years. Read the full article on Seeking Alpha

Seeking Alpha • Jan 06

Downgrading 3M Due To Persistent Litigation Risks And Stagnant Sales Growth

Summary I am downgrading 3M from hold to sell due to slow revenue growth, ongoing litigation risks, and inflated stock valuation despite recent gains. Revenue growth is expected to underpace inflation, driven by product line adjustments, declining European demand, and the healthcare spin-off. Despite settling some litigations, 3M faces significant pending lawsuits, posing substantial financial risks. Shares appear expensive when accounting for slow growth and litigation risks, with a fair value estimate of $86 per share, 34% below current trading. Read the full article on Seeking Alpha

Seeking Alpha • Dec 30

One Of JPMorgan's Value Picks For 2025, 3M Could Have A Bright Year Ahead

Summary JPMorgan highlights 3M Company as a key investment idea for 2025, despite ongoing legal challenges and growth issues, leading to my Hold rating. 3M's diverse operations span Safety & Industrial, Transportation & Electronics, Consumer, and Healthcare, with a strong focus on innovation and high-margin products. The company reported 1% organic growth and an 18% rise in adjusted EPS for Q3 2024, showcasing operational efficiency and cost management. With a healthy 23% margin and $1.5 billion free cash flow, MMM balances rewarding shareholders with investing in growth initiatives. Read the full article on Seeking Alpha

Seeking Alpha • Nov 25

3M: Seems A Bit Too Expensive Considering The Slow Growth

Summary Earlier this year, CEO William Brown said 3M's products are aging. Now and in the near future, it seems like the company is focussing on new products and research. It seems like the uncertainty-creating lawsuits are now largely settled, but the costs will weigh on the company for several years to come. Nevertheless, 3M has a strong financial position and rewards its shareholders with dividends and buybacks, but I'm waiting because I believe it is slightly too expensive. Read the full article on Seeking Alpha

Seeking Alpha • Oct 24

3M: Multiple Expansion But Problems Linger

Summary 3M's Q3 earnings beat expectations with $1.98/share, driven by margin expansion from restructuring, despite lackluster 1.5% organic revenue growth. The company repurchased $700 million in stock, raising concerns about prioritizing buybacks over addressing future PFAS liabilities and debt reduction. 3M faces significant PFAS-related lawsuits, posing potential billions in liabilities, making stock buybacks questionable given the financial risks. Despite a 30% stock appreciation, driven by multiple expansion, revenue growth remains below inflation, and future liabilities pose significant downside risks. Read the full article on Seeking Alpha

Seeking Alpha • Oct 01

3M's Transformation Uncertain: A Wait-And-See Approach

Summary 3M is undergoing a challenging transformation with stagnant revenue, rising debt, and significant legal risks from PFAS litigation, leading to a 32% stock price decline since 2021. Despite a strong global product portfolio and solid cash flow, current free cash flow is insufficient to cover dividends and share buybacks, raising concerns. New CEO William Brown brings valuable experience but skepticism remains about his ability to drive a radical transformation, given past performance and substantial PFAS liabilities. I estimate 3M's value at $125 per share, slightly lower than its current price, and recommend holding due to unclear recovery path. Read the full article on Seeking Alpha

Seeking Alpha • Aug 30

3M: A Bright Future, But Shares Hit Fair Value Amid Strong Momentum (Rating Downgrade)

Summary 3M's Q2 earnings report was exceptionally strong, leading to a 23% stock surge and a 46% YTD performance, the best in the DJIA. Despite robust technical momentum and a rising trend, 3M's stock is close to fair value, warranting a hold rating for now. Key risks include potential macroeconomic slowdowns, a strong US dollar, and an untested new CEO, but future EPS growth looks promising. With a decent 2.11% dividend yield and potential for payout boosts, 3M's long-term growth trajectory appears stable post-Solventum spinoff. I outline key price levels to monitor on chart, as momentum remains very impressive. Read the full article on Seeking Alpha

Neues Narrativ • Aug 20

Restructuring And Critical Shifts Poised To Transform Operational Efficiencies And Net Margins

Restructuring and focusing on high-growth areas like auto electrification and climate tech are set to drive margin expansions and top-line growth.

Seeking Alpha • Aug 01

3M's New CEO Spills The Beans

Summary 3M's core was tired before the new CEO, Bill Brown, took over. In the recent earnings call, he spilled the beans on this fact. He is displaying leadership and didn't mention AI one time, yet turning around the culture in a company like 3M is no small task. Investors who purchased 3M early this year and sold the Solventum shares have experienced gains exceeding 60%. My target price is $86. The market may move it to more like $110. Read the full article on Seeking Alpha

Gewinn- und Umsatzwachstumsprognosen

NYSE:MMM - Zukünftige Analystenschätzungen und Finanzdaten der Vergangenheit (USD Millions)
Datum	Umsatz	Gewinne	Freier Cashflow	Bargeld aus operativen Tätigkeiten	Durchschn. Anz. Analysten
12/31/2028	26,900	4,623	4,261	5,907	6
12/31/2027	25,900	4,638	4,230	5,034	13
12/31/2026	25,096	4,010	3,817	5,737	13
3/31/2026	25,024	2,787	2,060	2,959	N/A
12/31/2025	24,948	3,250	1,396	2,306	N/A
9/30/2025	24,825	3,401	1,588	2,541	N/A
6/30/2025	24,602	3,939	-1,983	-1,002	N/A
3/31/2025	24,513	4,420	-69	973	N/A
12/31/2024	24,575	4,009	638	1,819	N/A
9/30/2024	24,567	3,915	739	1,987	N/A
6/30/2024	24,543	16	4,277	5,684	N/A
3/31/2024	24,571	-8,359	4,657	6,172	N/A
12/31/2023	24,610	-8,402	5,065	6,680	N/A
9/30/2023	26,687	-8,495	4,853	6,616	N/A
6/30/2023	29,036	-2,109	4,444	6,237	N/A
3/31/2023	31,455	5,140	4,055	5,855	N/A
12/31/2022	26,161	4,013	3,842	5,591	N/A
9/30/2022	34,762	6,575	3,875	5,674	N/A
6/30/2022	35,085	4,150	4,310	6,017	N/A
3/31/2022	35,333	5,596	5,060	6,777	N/A
12/31/2021	35,355	5,921	5,851	7,454	N/A
9/30/2021	35,326	5,987	6,495	7,964	N/A
6/30/2021	34,734	5,983	7,076	8,570	N/A
3/31/2021	32,960	5,765	7,109	8,588	N/A
12/31/2020	32,184	5,449	6,612	8,113	N/A
9/30/2020	31,712	5,013	6,319	7,936	N/A
6/30/2020	31,353	5,166	5,880	7,478	N/A
3/31/2020	32,348	4,987	5,595	7,235	N/A
12/31/2019	32,136	4,517	N/A	7,070	N/A
9/30/2019	31,970	4,948	N/A	6,990	N/A
6/30/2019	32,131	4,908	N/A	7,107	N/A
3/31/2019	32,350	5,638	N/A	7,344	N/A
12/31/2018	32,765	5,349	N/A	6,439	N/A
9/30/2018	32,810	4,525	N/A	6,041	N/A
6/30/2018	32,830	4,411	N/A	5,652	N/A
3/31/2018	32,250	4,137	N/A	5,395	N/A
12/31/2017	31,657	4,858	N/A	6,240	N/A
9/30/2017	30,996	5,490	N/A	6,589	N/A
6/30/2017	30,533	5,390	N/A	6,747	N/A
3/31/2017	30,385	5,098	N/A	6,390	N/A
12/31/2016	30,109	5,050	N/A	6,662	N/A
9/30/2016	30,078	4,933	N/A	6,791	N/A
6/30/2016	30,081	4,900	N/A	6,547	N/A
3/31/2016	30,105	4,909	N/A	6,600	N/A
12/31/2015	30,274	4,833	N/A	6,420	N/A
9/30/2015	30,695	4,974	N/A	6,265	N/A
6/30/2015	31,120	4,981	N/A	6,312	N/A

Analystenprognosen zum zukünftigen Wachstum

Einkommen vs. Sparrate: MMMDas prognostizierte Gewinnwachstum (12.1% pro Jahr) liegt über der Sparquote (3.5%).

Ertrag vs. Markt: MMMDie Erträge des Unternehmens (12.1% pro Jahr) werden voraussichtlich langsamer wachsen als der Markt US (16.7% pro Jahr).

Hohe Wachstumserträge: MMMDie Erträge des Unternehmens werden voraussichtlich steigen, jedoch nicht deutlich.

Einnahmen vs. Markt: MMMDie Einnahmen des Unternehmens (2.8% pro Jahr) werden voraussichtlich langsamer wachsen als der Markt US (11.7% pro Jahr).

Hohe Wachstumseinnahmen: MMMDie Einnahmen des Unternehmens (2.8% pro Jahr) werden voraussichtlich langsamer wachsen als 20% pro Jahr.

Wachstumsprognosen für den Gewinn je Aktie

Künftige Eigenkapitalrendite

Künftige Eigenkapitalrendite: MMMDie Eigenkapitalrendite des Unternehmens wird in 3 Jahren voraussichtlich sehr hoch sein (69.9%).

Wachstumsunternehmen entdecken

Unternehmensanalyse und Finanzdaten Status

Daten	Zuletzt aktualisiert (UTC-Zeit)
Unternehmensanalyse	2026/05/15 22:00
Aktienkurs zum Tagesende	2026/05/15 00:00
Gewinne	2026/03/31
Jährliche Einnahmen	2025/12/31

Datenquellen

Die in unserer Unternehmensanalyse verwendeten Daten stammen von S&P Global Market Intelligence LLC. Die folgenden Daten werden in unserem Analysemodell verwendet, um diesen Bericht zu erstellen. Die Daten sind normalisiert, was zu einer Verzögerung bei der Verfügbarkeit der Quelle führen kann.

Paket	Daten	Zeitrahmen	Beispiel US-Quelle ^*
Finanzdaten des Unternehmens	10 Jahre	Gewinn- und Verlustrechnung Kapitalflussrechnung Bilanz	SEC-Formular 10-K SEC-Formular 10-Q
Konsensschätzungen der Analysten	+3 Jahre	Finanzielle Vorausschau Kursziele der Analysten	Analysten Research Berichte Blue Matrix
Marktpreise	30 Jahre	Aktienkurse Dividenden, Splits und Aktionen	ICE-Marktdaten SEC-Formular S-1
Eigentümerschaft	10 Jahre	Top-Aktionäre Insiderhandel	SEC-Formular 4 SEC-Formular 13D
Verwaltung	10 Jahre	Das Führungsteam Direktorium	SEC-Formular 10-K SEC-Formular DEF 14A
Wichtige Entwicklungen	10 Jahre	Ankündigungen des Unternehmens	SEC-Formular 8-K

* Beispiel für US-Wertpapiere, für nicht-US-amerikanische Wertpapiere werden gleichwertige regulatorische Formulare und Quellen verwendet.

Sofern nicht anders angegeben, beziehen sich alle Finanzdaten auf einen Jahreszeitraum, werden aber vierteljährlich aktualisiert. Dies wird als Trailing Twelve Month (TTM) oder Last Twelve Month (LTM) Daten bezeichnet. Erfahren Sie mehr.

Analysemodell und Schneeflocke

Einzelheiten zu dem Analysemodell, mit dem dieser Bericht erstellt wurde, finden Sie auf unserer Github-Seite. Außerdem bieten wir Leitfäden zur Verwendung unserer Berichte und Tutorials auf YouTube an.

Erfahren Sie mehr über das Weltklasse-Team, das das Simply Wall St-Analysemodell entworfen und entwickelt hat.

Metriken für Industrie und Sektor

Unsere Branchen- und Sektionskennzahlen werden alle 6 Stunden von Simply Wall St berechnet. Details zu unserem Verfahren finden Sie auf Github.

Analysten-Quellen

3M Company wird von 30 Analysten beobachtet. 13 dieser Analysten hat die Umsatz- oder Gewinnschätzungen übermittelt, die als Grundlage für unseren Bericht dienen. Die von den Analysten übermittelten Daten werden im Laufe des Tages aktualisiert.

Analyst	Einrichtung
John Eade	Argus Research Company
Julian Mitchell	Barclays
Robert Cornell	Barclays

3M Zukünftiges Wachstum

Future Kriterienprüfungen 2/6

Wichtige Informationen

Jüngste Aktualisierungen zum künftigen Wachstum

3M Company Revises Earnings Guidance for the Full Year 2025

3M Company Provides Earnings Guidance for the Year 2025

Consensus EPS estimates increase by 10%

Price target increased by 12% to US$121

Recent updates

First quarter dividend of US$0.78 announced

3M: Iran Conflict And Inflationary Pressure Could Derail The Recovery

3M Company Declares Quarterly Dividend for the Second Quarter of 2026, Payable on June 12, 2026

3M Tops Q1 Earnings Forecast With Strong Margins and Steady Data Center Push

Executive VP exercised options to buy US$1.1m worth of stock.

MMM: Future Margin Execution And Buybacks Will Support Turnaround Prospects

First quarter 2026 earnings: EPS misses analyst expectations

MMM: Execution On Margin Efficiency And Buybacks Will Support Future Re Rating

3M Company (MMM): The "Industrial Rebirth" and the 2026 Operational Pivot

Insider exercised options to buy US$80k worth of stock.

MMM: Operational Discipline And Legal Resolution Will Support Future Re Rating

3M Company, Annual General Meeting, May 12, 2026

MMM: Operational Progress And Legal Overhang Resolution Will Support Future Re Rating

MMM: Digital And Legal Progress Will Support Future Re Rating

3M Company Introduces Brite by Scotch-Brite Collection of Kitchen Cleaning Tools

MMM: Digital Execution And Slightly Higher Fair Value Will Support Re Rating

3M Company Appoints Meagan Linn as Senior Vice President, Government Affairs

Insider recently sold US$310k worth of stock

Insider notifies of intention to sell stock

Fourth quarter dividend increased to US$0.78

MMM: Turnaround Prospects Will Be Tested By PFAS Litigation And Mixed Street Expectations

3M Company Appoints Neil G. Mitchill to Board of Directors and Member of the Audit Committee and the Nominating and Governance Committee of the Board, Effective Feb. 6, 2026

3M Company Declares Quarterly Dividend, Payable on March 12, 2026

MMM: New Digital Tools And Higher P E Multiple Will Support Re Rating

Now 20% undervalued after recent price drop

MMM: Reset Expectations And New Products Will Support Higher Margins

Montana Court Denies Motions to Dismiss Class-Action Lawsuit Fighting PFAS in Firefighter Turnout Gear

3M to Debut AI-Powered Assistant 'Ask 3M' and Expanded 3M Digital Materials Hub At CES 2026

MMM: PFAS Litigation Will Ultimately Cap Upside Despite Turnaround Progress

3M to Showcase Industry-Advancing Solutions, New Ai-Powered Innovation Tool At Ces 2026

MMM: Turnaround Progress Will Face Ongoing PFAS Litigation And Portfolio Reshaping Risks

MMM: Shares Will Balance Turnaround Progress With Litigation and Asset Sale Uncertainty

Insider notifies of intention to sell stock

Third quarter dividend of US$0.73 announced

MMM: Shares Will Balance Turnaround Progress With Ongoing Litigation and Portfolio Changes

3M Company Declares Dividend for the Fourth Quarter of 2025, Payable Dec. 12, 2025

Insider notifies of intention to sell stock

Third quarter 2025 earnings: Revenues exceed analysts expectations while EPS lags behind

3M Company Revises Earnings Guidance for the Full Year 2025

Analysts Divided on 3M as Fair Value Rises Amid New Initiatives and Persistent Risks

Now 21% undervalued after recent price drop

New Product Launches And Efficiency Gains Will Boost Future Value

3M Reportedly Weighs Multibillion-Dollar Carve-Out in Industrials Arm

3M to Showcase Its Latest Innovative Solutions for the Automobile Industry Exhibition

Second quarter dividend of US$0.73 announced

3M Company Declares Quarterly Dividend for the Third Quarter of 2025, Payable on September 12, 2025

New minor risk - Insider selling

Now 20% undervalued

New major risk - Earnings quality

Second quarter 2025 earnings: Revenues exceed analysts expectations while EPS lags behind

Executive VP notifies of intention to sell stock

ScotchBlue PROSharp™? Painter's Tape with Edge-Lock+ Technology

First quarter dividend of US$0.73 announced

3M Company Declares Dividend for the Second Quarter of 2025, Payable on June 12, 2025

3M Company Resolves PFAS-Related Claims with the State of New Jersey

First quarter 2025 earnings: EPS exceeds analyst expectations

FUTURO Brand Introduces Collection of Rededed Premium Compression Sleeves for Muscle and Joint Support

Now 21% overvalued after recent price rise

3M Company, Annual General Meeting, May 13, 2025

3M: Multiple Expansion Amidst Turnaround Success

Now 20% overvalued after recent price rise

3M Company Announces Retirement of Group President, Enterprise Supply Chain, Peter Gibbons, Effective from April 2, 2025

Insider exercised options to buy US$1.0m worth of stock.

3M Company Announces Executive and Board Changes

3M: More Upside Ahead - But Wait For A Moderate Retracement

3M Company (NYSE:MMM) announces an Equity Buyback for $7,500 million worth of its shares.

New minor risk - Insider selling

Executive Chairman notifies of intention to sell stock

3M Company Provides Earnings Guidance for the Year 2025

3M Is Structurally Shifting For Durable Growth

Full year 2024 earnings: EPS in line with analyst expectations despite revenue beat